Listed

Arbutus Biopharma Corp: Form 10-Q for the period ended Sep 30, 2015

Filed with the SEC on Nov 5, 2015 and accepted by EDGAR at Nov 5, 2015, 16:37 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-07-01 to 2015-09-30$4.1mus-gaap:Revenues
Revenue6 months2015-04-01 to 2015-09-30$4.1mus-gaap:Revenues
Revenue9 months2015-01-01 to 2015-09-30$12.2mus-gaap:Revenues
Research and development3 months2015-07-01 to 2015-09-30$16.4mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2015-01-01 to 2015-09-30$36.6mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2015-07-01 to 2015-09-30−$58.1mus-gaap:OperatingIncomeLoss
Operating income9 months2015-01-01 to 2015-09-30−$90.6mus-gaap:OperatingIncomeLoss
Income tax3 months2015-07-01 to 2015-09-30−$15.2mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2015-01-01 to 2015-09-30−$15.2mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-07-01 to 2015-09-30−$29.0mus-gaap:NetIncomeLoss
Net income9 months2015-01-01 to 2015-09-30−$55.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-07-01 to 2015-09-30−$0.57us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2015-01-01 to 2015-09-30−$1.28us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2015-07-01 to 2015-09-30−$2.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Operating cash flow9 months2015-01-01 to 2015-09-30−$38.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2015-07-01 to 2015-09-30$589.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Capital expenditure9 months2015-01-01 to 2015-09-30$1.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-09-30$181.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-09-30$200.0mus-gaap:AssetsCurrent
Total assetsAt period end2015-09-30$722.6mus-gaap:Assets
Current liabilitiesAt period end2015-09-30$13.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-09-30$168.8mus-gaap:Liabilities
Shareholders' equityAt period end2015-09-30$553.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001062993-15-005809. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.